End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.17 CNY | -0.22% | -2.45% | +23.58% |
Apr. 11 | Ose Immuno receives funding from Bpifrance | CF |
Mar. 19 | HLA to Redeem Convertible Bonds Early | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The group's high margin levels account for strong profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company is one of the best yield companies with high dividend expectations.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Apparel & Accessories
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+23.58% | 6.09B | C | ||
-2.29% | 1.13B | - | ||
+0.80% | 783M | - | ||
-10.39% | 781M | - | ||
+12.29% | 724M | - | ||
+9.17% | 546M | - | - | |
-3.14% | 532M | - | ||
+24.96% | 280M | C | ||
-36.02% | 146M | - | - | |
-33.24% | 97.6M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 600398 Stock
- Ratings Hla Group Corp., Ltd.